Search
for
Sort by
Research 91–120 of 877
- Oral abrocitinib for treatment of refractory alopecia areata: A retrospective study
- Prevention and Treatment of Chemotherapy-Induced Alopecia: What Is Available and What Is Coming?
- Drug Reactions Affecting Hair: Diagnosis
- Bimatoprost in the treatment of eyelash universalis alopecia areata
- Bimatoprost solution 0·03% topical application to the eyelid margin for the treatment of eyelash hypotrichosis
- Instilled bimatoprost ophthalmic solution in patients with eyelash alopecia areata
- Effectiveness of Baricitinib for Nasal, Genital, and Beard Hair Regrowth in Patients with Severe Alopecia Areata: 12-Month Outcomes from a Prospective Observational Study
- Baricitinib Provides Significant Hair Regrowth In Adolescents With Severe Alopecia Areata: 52-Week Efficacy and Safety Results From A Phase 3 Randomized, Controlled Trial
- Enhancing the Growth of Natural Eyelashes: The Mechanism of Bimatoprost-Induced Eyelash Growth
- Bimatoprost for the treatment of eyelash, eyebrow and scalp alopecia
- The eyelash follicle features and anomalies: A review
- Safety and Efficacy of Bimatoprost Solution 0.03% Topical Application in Patients with Chemotherapy-Induced Eyelash Loss
- Madarosis, milphosis, eyelash trichomegaly, and dermatochalasis
- Lipid nanocarriers as innovative strategies for hair regrowth
- Prediction of Long-term Scalp Hair Regrowth at 24 Months in Patients with Alopecia Areata Receiving Ritlecitinib Treatment in the ALLEGRO Clinical Trial Program
- Long‐term safety and efficacy of bimatoprost solution 0·03% application to the eyelid margin for the treatment of idiopathic and chemotherapy‐induced eyelash hypotrichosis: a randomized controlled trial
- An evaluation of the safety and efficacy of bimatoprost for eyelash growth in pediatric subjects
- Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
- Madarosis
- Bimatoprost in the treatment of eyelash hypotrichosis
- Phosphodiesterase inhibitors and prostaglandin analogues in dermatology: A comprehensive review
- Eyebrow and Eyelash Alopecia: A Clinical Review
- Therapeutic potential of bimatoprost for the treatment of eyebrow hypotrichosis
- Alopecia Possibly Secondary to Topical Ophthalmic β-Blockers
- Ruxolitinib found to cause eyelash growth: a case report
- Ethnic Considerations in Hair Restoration Surgery
- Head and Neck Reconstruction
- A Randomized, Double-Blind, Placebo-Controlled Pilot Study to Evaluate the Efficacy and Safety of Latanoprost for Eyelash Growth in Aesthetic Medicine
- Psychometric Properties of the EQ-5D-5L in Patients with Alopecia Areata
- Isolated long white eyelash: An underrecognized trichologic finding